A Study of TAK-919 in Healthy Japanese Adults (COVID-19)

Clinical trial NCT04677660 · COMPLETED

Trial details

NCT number: NCT04677660
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease (COVID-19)

Start date: 2021-01-07
Primary completion: 2022-02-22
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.